Trial intelligence / Profile preview

Fertilo vs Medicult IVM for In Vitro Maturation

NCT06858111Phase 3Recruiting

Sponsor
Gameto
Start
Apr 2025
Primary completion
May 2027
Modality
Patient-derived iPSCs, Allogeneic iPSCs
Countries
1
01

Overview

Phase 3, randomised trial of Fertilo in infertility (2 arms), sponsored by Gameto. Primary endpoint: Number of ongoing pregnancies. Started Apr 2025; status: recruiting.

02

Drugs

Fertilo
03

Conditions

infertility

Beyond the preview

Go deeper on NCT06858111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06858111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call